William Cole alias The Hopium Dealer
running the vibes clinic at Functional Medicine Practitioner
Website · drwillcole.com
Practice location
521.00 Get in touch 111 Whitehead Lane Suite 100
Monroeville, PA 15146
Funnel-first framing that runs on persuasion, light on published evidence.
High grift signals
Score breakdown
Direct answer
William Cole is licensed in Pennsylvania as a chiropractor (DC), not as an MD or DO, and Pennsylvania's chiropractic scope statute (Act 188 of 1986) limits that license to musculoskeletal care, not the diagnosis or treatment of systemic disease. Even so, they advertise diagnosing or treating Chronic Lyme Disease, Mold Toxicity, Autoimmune Diseases, Diabetes, and Infertility, conditions that belong with infectious-disease physicians, rheumatologists, and allergy and immunology specialists. Those same pages route patients toward supplements, lab panels, and paid programs that William Cole profits from.
Key findings
- False Authority: Uses 'Dr.' from a narrow chiropractic license (DC) to imply broad medical authority for systemic diseases like Lyme, diabetes, and autoimmune conditions, which are outside chiropractic scope.see section ↓
- Claim "chronic Lyme disease": not supported by peer-reviewed evidence.see section ↓
- Claim "Mold toxicity": mixed in the medical literature.see section ↓
- NPI registry confirms Will Cole as Chiropractor (DC) in Pennsylvania (NPI 1437487295).see section ↓
- William Cole shows credential inflation relative to stated vs likely credentials.see section ↓
- Dr William Cole is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
- Against Pennsylvania State Board of Chiropractic scope rules (Act 188 of 1986), these advertised activities appear outside William Cole's license (including conditions they merely list as ones they treat): Chronic Lyme Disease, Mold Toxicity, Autoimmune Diseases.see section ↓
- 24 of 24 advertised activities fall outside permitted Chiropractor scope in PA.see section ↓
Claims & evidence
23 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Chronic Lyme Disease.
Chronic Lyme Disease
- Supports
- There is no support in the provided index papers for the specific claim of chronic Lyme disease. None of the listed papers address Lyme disease, persistent Borrelia infection, or the controversial syndrome often called chronic Lyme disease.
- Contradicts
- The provided index list is unrelated to Lyme disease and therefore does not support the claim. In mainstream evidence reviews, persistent symptoms after treated Lyme disease are recognized, but prolonged or repeated antibiotic treatment has not shown sustained benefit in randomized trials and is associated with harms; this makes the broad concept of chronic Lyme disease as ongoing active infection weakly supported at best. The current indexed papers do not provide any direct evidence for or against Lyme disease specifically.
- Mainstream view
- The mainstream medical view is that Lyme disease can cause persistent symptoms after appropriate treatment in a subset of patients, but the term chronic Lyme disease is not a well-defined diagnosis and is not generally accepted as evidence of ongoing infection. Major guidelines typically recommend evaluating alternative causes of symptoms and do not endorse long-term antibiotics for nonspecific chronic symptoms attributed to Lyme disease.
“Chronic Lyme Disease”
Rule: Act 188 of 1986
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Mold Toxicity.
Mold Toxicity
- Supports
- High-quality epidemiologic evidence and major health-agency guidelines support that indoor dampness and visible mold are associated with increased risk of respiratory and allergic disease, including asthma development and exacerbation, upper and lower respiratory symptoms, allergic rhinitis, and some infections.[2][5][15][19] These data underpin WHO guidelines on indoor air quality that identify dampness and mold as contributors to increased prevalences of respiratory symptoms, allergies, and asthma.[19] Reviews from bodies such as the Institute of Medicine and WHO, as well as more recent systematic reviews, consistently find that remediation of dampness and mold (fixing leaks, improving ventilation, removing moldy materials) reduces respiratory symptoms and asthma morbidity.[5][11][19] There is also growing but still emerging evidence that living in damp, moldy housing is linked to worse mental health outcomes via psychosocial stress and possibly biological pathways.[6] Toxicological and occupational literature shows that very high-level exposures to certain mycotoxins (usually via contaminated food, occupational dusts, or unusual indoor situations) can cause systemic toxicity affecting organs such as the kidneys, liver, nervous system, and developing fetus, and some mycotoxins are proven carcinogens, but these scenarios typically involve doses far above typical residential exposure and are not specific to ordinary household mold.[16][20]
- Contradicts
- Major evidence reviews from the Institute of Medicine and WHO have concluded that the available data are insufficient to support a causal link between inhaled indoor mycotoxins at usual environmental levels and broad, nonspecific systemic symptom clusters often marketed as “toxic mold syndrome” or chronic inflammatory response syndrome (CIRS).[19][23] The American Academy of Allergy, Asthma & Immunology and medical toxicology position statements similarly report that while mold-related allergies and asthma exacerbations are well established, evidence does not support inhaled mycotoxins as a cause of chronic, multi-system toxicity in otherwise healthy individuals at typical indoor exposure levels.[12][23][24] Epidemiologic studies show correlations between dampness/mold and a wide range of symptoms (respiratory, neurological, cognitive, dermatologic), but most are observational; causality, specific dose–response relationships for mycotoxins, and objective biomarkers of “mold toxicity” in the sense promoted by influencers remain weak or unproven.[2][5][17][23] Well-studied molds such as Stachybotrys chartarum are recognized as potential producers of mycotoxins, yet years of intensive study have failed to establish exposure to this species in homes, schools, or offices as a proven cause of systemic human toxicity, beyond allergic and irritant effects.[22] Claims that typical household mold exposure routinely causes severe systemic illness, autoimmunity, or chronic neurocognitive decline in the general population are not supported by current high-quality evidence and are considered speculative by mainstream allergy and toxicology organizations.[12][23][24]
- Mainstream view
- Mainstream medical and public health consensus is that indoor dampness and mold are important environmental hazards primarily because they worsen or contribute to respiratory and allergic diseases (asthma, rhinitis, cough, wheeze, respiratory infections) and can, in high-risk or heavily exposed populations, contribute to certain infections and rare hypersensitivity pneumonitis.[14][15][18][19] The recommended clinical and public health response focuses on identifying and correcting moisture problems, removing moldy materials, managing asthma and allergies using standard evidence-based therapies, and protecting immunocompromised individuals and those with chronic lung disease who may be at risk for opportunistic fungal infections.[14][18][19] Mainstream guidelines and expert societies do not endorse a distinct diagnostic entity of “mold toxicity” or “toxic mold syndrome” as a well-validated, systemic disease caused by typical indoor mold exposure; instead, they emphasize established allergic, irritant, and infectious mechanisms and caution against overdiagnosis and unproven detoxification regimens.[12][19][23][24] High-dose mycotoxin toxicity is acknowledged in toxicology and occupational medicine, but it is treated as a separate issue from everyday residential mold, with concern focused on contaminated food, heavy occupational exposure, or exceptional environmental conditions rather than routine home or office dampness.[16][20][22] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Mold Toxicity”
Rule: Act 188 of 1986
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Autoimmune Diseases.
Autoimmune Diseases
- Supports
- High-quality reviews define autoimmune diseases as conditions where the immune system inappropriately targets the body’s own cells and tissues, often via autoreactive T and B cells and pathogenic autoantibodies, leading to chronic inflammation and organ dysfunction.[1][2][3][4][5][6][14][20][21] Large epidemiologic analyses and reviews indicate that there are more than 80–100 distinct autoimmune diseases, with common examples including type 1 diabetes, multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, psoriasis, celiac disease, autoimmune thyroid disease, inflammatory bowel disease, Sjögren’s syndrome, and autoimmune hepatitis.[1][3][6][14][18][21] Background reviews and national health agencies report that autoimmune diseases collectively affect roughly 3–10% of the population, with recent data suggesting rising incidence and prevalence over recent decades.[15][17][18][21][24] Systematic and guideline-level work shows that autoimmune diseases typically result from interactions between genetic susceptibility (e.g., HLA variants, other risk alleles) and environmental exposures (infections, chemicals, diet, drugs, smoking, UV, microbiome) that lead to breakdown of immune tolerance.[1][2][3][7][14][15][18][21][24] Major rheumatology and hepatology guidelines (e.g., for rheumatoid arthritis, spondyloarthropathies, autoimmune hepatitis) emphasize immunomodulatory or immunosuppressive therapy as standard of care, including corticosteroids, conventional disease-modifying antirheumatic drugs, and targeted biologic agents such as TNF inhibitors, with substantial evidence from randomized trials and meta-analyses that these reduce disease activity and prevent damage.[4][5][13][19][22][25]
- Contradicts
- The indexed clinical trials provided (perioperative chemotherapy plus toripalimab for EBV-associated gastric cancer, home caffeine for apnea of prematurity, axitinib with radiotherapy for hepatocellular carcinoma, and antimicrobial photodynamic therapy for dental biofilm) are not autoimmune-focused and therefore do not provide direct evidence about autoimmune disease pathogenesis, prevalence, or standard treatment, limiting their relevance to the claim. Although debates exist around specific environmental triggers or proposed novel therapeutics (such as helminth or schistosome-derived antigens), current evidence is largely preclinical or early-phase and does not yet support broad claims that such approaches are established treatments or “cures” for autoimmune diseases.[7][8] High-quality reviews and guidelines repeatedly state that most autoimmune diseases have no definitive cure and require long-term management, which contradicts any influencer claim that autoimmune diseases are generally curable with simple or single interventions.[11][14][15][17][21][22][23] Evidence on the exact reasons for the rising prevalence is still incomplete and multifactorial, so strong causal claims attributing the increase to one predominant factor (e.g., one chemical, one food type, or a single vaccine) are not supported by systematic epidemiologic reviews.[7][14][15][18][21][24]
- Mainstream view
- Mainstream medical and scientific consensus is that autoimmune diseases are a large, heterogeneous group of chronic disorders in which the immune system mistakenly targets self-antigens, driven by complex interactions of genetic predisposition and environmental factors, and manifesting as organ-specific or systemic inflammation and damage.[1][2][3][4][5][6][14][20][21] There are more than 80 recognised autoimmune diseases, collectively affecting several percent of the population, with incidence and prevalence increasing over recent decades.[14][15][17][18][21][24] For most autoimmune diseases, there is no cure; instead, standard care focuses on early diagnosis, risk stratification, and long-term management using immunomodulatory or immunosuppressive therapies (including biologics and small molecules) to control disease activity, prevent tissue damage, and improve quality of life.[4][5][11][13][19][21][22][23][25] Current guidelines and high-quality reviews emphasise individualized treatment plans, monitoring for adverse effects, and, increasingly, targeted therapies informed by molecular, omics, and epigenetic insights, but they do not support simplistic or universal “reverse autoimmune disease” strategies.[1][3][5][9][10][16][22] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Autoimmune Diseases”
Rule: Act 188 of 1986
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Diabetes.
Diabetes
- Supports
- High-quality evidence shows that diet and other non-pharmacological strategies are central to both prevention and management of type 2 diabetes, and in some cases can induce remission. [17][24] Umbrella reviews and systematic reviews demonstrate that structured, energy-restricted dietary programs (including very low energy diets and formula-based total diet replacement) can produce substantial weight loss, improved glycaemic control, and diabetes remission in a significant proportion of adults with type 2 diabetes, at least over 6–12 months. [18][21] Multiple randomized-controlled-trial meta-analyses summarized in umbrella reviews indicate that plant-based, Mediterranean, low-carbohydrate (<26% energy), and high-protein diets, when energy-restricted, can improve HbA1c, body weight, triglycerides, and other cardiometabolic markers in people with type 2 diabetes. [20][22] The American College of Lifestyle Medicine expert consensus supports diet as a primary intervention capable of achieving type 2 diabetes remission in some patients, especially when it leads to major weight loss, although this consensus is based on mixed levels of evidence rather than solely high-certainty RCTs. [23] High-quality umbrella and systematic reviews of diet and diabetes incidence show that Mediterranean and DASH-style patterns, and higher intake of whole grains, fiber, low-fat dairy, olive oil, and other nutrient-dense foods, significantly reduce the risk of developing type 2 diabetes, consistent with a strong preventive role of diet. [19] Major guidelines and consensus reports (ADA/EASD) explicitly recognize lifestyle modification (diet, physical activity, weight management) as foundational therapy for type 2 diabetes and formally define “remission” (HbA1c <6. 5% for at least 3 months off glucose-lowering medication), acknowledging that remission is achievable though not guaranteed.
- Contradicts
- Despite strong evidence that intensive dietary and lifestyle interventions can improve glycaemic control and sometimes induce remission, high-quality umbrella reviews highlight that most remission data are limited to around one year, and long-term durability beyond 2 years is uncertain or poorly studied. Evidence comparing specific macronutrient patterns is mixed: meta-analyses of hypocaloric diets for type 2 diabetes do not consistently support any one macronutrient profile (e. [17][18][21] g. , low carbohydrate versus higher carbohydrate) as clearly superior for long-term weight management, and some low-carbohydrate or ketogenic diet remission results come from studies with serious or critical risk of bias and very low certainty. [24] The ADA/EASD consensus views type 2 diabetes as generally chronic and progressive, meaning that while remission is possible in some individuals, most patients will not achieve durable drug-free remission solely through diet, and many will need ongoing pharmacologic therapy in addition to lifestyle change. [23] Umbrella reviews emphasize that diet interventions are beneficial but not curative for the majority; they reduce risk and improve control rather than reliably eliminating the disease, and benefits often decline with weight regain or reduced adherence, indicating that claims of simple or universal dietary cures are not supported by current evidence. [19][20][22]
- Mainstream view
- Mainstream medical and scientific consensus is that type 2 diabetes is a chronic, usually progressive metabolic disease strongly influenced by lifestyle and diet, but not typically “cured”; instead, it can often be well controlled, and in some patients can enter remission, particularly after substantial weight loss and sustained dietary change. [19][22][23][24] Current high-quality evidence and major guidelines agree that healthy, energy-restricted dietary patterns and comprehensive lifestyle interventions are first-line, foundational therapy for prevention and management of type 2 diabetes, but pharmacologic treatment (e. [17] g. , metformin and other glucose-lowering agents) is usually required for many patients to achieve and maintain target glycaemic levels. Diet-based, weight-loss–focused interventions can induce remission in a subset of patients, especially early in the disease course and when significant weight loss is achieved, yet remission is not guaranteed, may be time-limited, and requires ongoing monitoring because vascular and other complication risks may persist. Accordingly, mainstream practice encourages intensive lifestyle modification for all patients with or at risk for type 2 diabetes, while also using medications, and increasingly discussing remission as a realistic but conditional goal rather than a universal outcome. [18][21] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Diabetes”
Rule: Act 188 of 1986
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Infertility.
Infertility
No specific health claims of theirs were cross-checked against the literature.
“Infertility”
Rule: Act 188 of 1986
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Thyroid Health.
Thyroid Health
No specific health claims of theirs were cross-checked against the literature.
“Thyroid Health”
Rule: Act 188 of 1986
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Anxiety & Depression.
Anxiety & Depression
No specific health claims of theirs were cross-checked against the literature.
“Anxiety & Depression”
Rule: Act 188 of 1986
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Perimenopause Menopause Symptoms.
Perimenopause Menopause Symptoms
No specific health claims of theirs were cross-checked against the literature.
“Perimenopause Menopause Symptoms”
Rule: Act 188 of 1986
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Chronic Fatigue.
Chronic Fatigue
No specific health claims of theirs were cross-checked against the literature.
“Chronic Fatigue”
Rule: Act 188 of 1986
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure diagnosis from POTS and dysautonomia.
diagnosis from POTS and dysautonomia
No specific health claims of theirs were cross-checked against the literature.
“diagnosis from POTS and dysautonomia”
Rule: Act 188 of 1986
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to advertise Autoimmune Health as within their scope of practice.
Autoimmune Health
No specific health claims of theirs were cross-checked against the literature.
“Autoimmune Health”
Rule: Act 188 of 1986
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Leaky Gut Quiz.
Leaky Gut Quiz
No specific health claims of theirs were cross-checked against the literature.
“Leaky Gut Quiz”
Rule: Act 188 of 1986
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Thyroid Quiz.
Thyroid Quiz
No specific health claims of theirs were cross-checked against the literature.
“Thyroid Quiz”
Rule: Act 188 of 1986
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Treating systemic infectious disease (Chronic Lyme Disease).
Treating systemic infectious disease (Chronic Lyme Disease)
- Supports
- There is no support in the provided index papers for the specific claim of chronic Lyme disease. None of the listed papers address Lyme disease, persistent Borrelia infection, or the controversial syndrome often called chronic Lyme disease.
- Contradicts
- The provided index list is unrelated to Lyme disease and therefore does not support the claim. In mainstream evidence reviews, persistent symptoms after treated Lyme disease are recognized, but prolonged or repeated antibiotic treatment has not shown sustained benefit in randomized trials and is associated with harms; this makes the broad concept of chronic Lyme disease as ongoing active infection weakly supported at best. The current indexed papers do not provide any direct evidence for or against Lyme disease specifically.
- Mainstream view
- The mainstream medical view is that Lyme disease can cause persistent symptoms after appropriate treatment in a subset of patients, but the term chronic Lyme disease is not a well-defined diagnosis and is not generally accepted as evidence of ongoing infection. Major guidelines typically recommend evaluating alternative causes of symptoms and do not endorse long-term antibiotics for nonspecific chronic symptoms attributed to Lyme disease.
“Chronic Lyme Disease”
Rule: Act 188 of 1986
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Treating systemic toxic exposure (Mold Toxicity).
Treating systemic toxic exposure (Mold Toxicity)
- Supports
- High-quality epidemiologic evidence and major health-agency guidelines support that indoor dampness and visible mold are associated with increased risk of respiratory and allergic disease, including asthma development and exacerbation, upper and lower respiratory symptoms, allergic rhinitis, and some infections.[2][5][15][19] These data underpin WHO guidelines on indoor air quality that identify dampness and mold as contributors to increased prevalences of respiratory symptoms, allergies, and asthma.[19] Reviews from bodies such as the Institute of Medicine and WHO, as well as more recent systematic reviews, consistently find that remediation of dampness and mold (fixing leaks, improving ventilation, removing moldy materials) reduces respiratory symptoms and asthma morbidity.[5][11][19] There is also growing but still emerging evidence that living in damp, moldy housing is linked to worse mental health outcomes via psychosocial stress and possibly biological pathways.[6] Toxicological and occupational literature shows that very high-level exposures to certain mycotoxins (usually via contaminated food, occupational dusts, or unusual indoor situations) can cause systemic toxicity affecting organs such as the kidneys, liver, nervous system, and developing fetus, and some mycotoxins are proven carcinogens, but these scenarios typically involve doses far above typical residential exposure and are not specific to ordinary household mold.[16][20]
- Contradicts
- Major evidence reviews from the Institute of Medicine and WHO have concluded that the available data are insufficient to support a causal link between inhaled indoor mycotoxins at usual environmental levels and broad, nonspecific systemic symptom clusters often marketed as “toxic mold syndrome” or chronic inflammatory response syndrome (CIRS).[19][23] The American Academy of Allergy, Asthma & Immunology and medical toxicology position statements similarly report that while mold-related allergies and asthma exacerbations are well established, evidence does not support inhaled mycotoxins as a cause of chronic, multi-system toxicity in otherwise healthy individuals at typical indoor exposure levels.[12][23][24] Epidemiologic studies show correlations between dampness/mold and a wide range of symptoms (respiratory, neurological, cognitive, dermatologic), but most are observational; causality, specific dose–response relationships for mycotoxins, and objective biomarkers of “mold toxicity” in the sense promoted by influencers remain weak or unproven.[2][5][17][23] Well-studied molds such as Stachybotrys chartarum are recognized as potential producers of mycotoxins, yet years of intensive study have failed to establish exposure to this species in homes, schools, or offices as a proven cause of systemic human toxicity, beyond allergic and irritant effects.[22] Claims that typical household mold exposure routinely causes severe systemic illness, autoimmunity, or chronic neurocognitive decline in the general population are not supported by current high-quality evidence and are considered speculative by mainstream allergy and toxicology organizations.[12][23][24]
- Mainstream view
- Mainstream medical and public health consensus is that indoor dampness and mold are important environmental hazards primarily because they worsen or contribute to respiratory and allergic diseases (asthma, rhinitis, cough, wheeze, respiratory infections) and can, in high-risk or heavily exposed populations, contribute to certain infections and rare hypersensitivity pneumonitis.[14][15][18][19] The recommended clinical and public health response focuses on identifying and correcting moisture problems, removing moldy materials, managing asthma and allergies using standard evidence-based therapies, and protecting immunocompromised individuals and those with chronic lung disease who may be at risk for opportunistic fungal infections.[14][18][19] Mainstream guidelines and expert societies do not endorse a distinct diagnostic entity of “mold toxicity” or “toxic mold syndrome” as a well-validated, systemic disease caused by typical indoor mold exposure; instead, they emphasize established allergic, irritant, and infectious mechanisms and caution against overdiagnosis and unproven detoxification regimens.[12][19][23][24] High-dose mycotoxin toxicity is acknowledged in toxicology and occupational medicine, but it is treated as a separate issue from everyday residential mold, with concern focused on contaminated food, heavy occupational exposure, or exceptional environmental conditions rather than routine home or office dampness.[16][20][22] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Mold Toxicity”
Rule: Act 188 of 198
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Treating systemic autoimmune conditions (Autoimmune Diseases).
Treating systemic autoimmune conditions (Autoimmune Diseases)
- Supports
- High-quality reviews define autoimmune diseases as conditions where the immune system inappropriately targets the body’s own cells and tissues, often via autoreactive T and B cells and pathogenic autoantibodies, leading to chronic inflammation and organ dysfunction.[1][2][3][4][5][6][14][20][21] Large epidemiologic analyses and reviews indicate that there are more than 80–100 distinct autoimmune diseases, with common examples including type 1 diabetes, multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, psoriasis, celiac disease, autoimmune thyroid disease, inflammatory bowel disease, Sjögren’s syndrome, and autoimmune hepatitis.[1][3][6][14][18][21] Background reviews and national health agencies report that autoimmune diseases collectively affect roughly 3–10% of the population, with recent data suggesting rising incidence and prevalence over recent decades.[15][17][18][21][24] Systematic and guideline-level work shows that autoimmune diseases typically result from interactions between genetic susceptibility (e.g., HLA variants, other risk alleles) and environmental exposures (infections, chemicals, diet, drugs, smoking, UV, microbiome) that lead to breakdown of immune tolerance.[1][2][3][7][14][15][18][21][24] Major rheumatology and hepatology guidelines (e.g., for rheumatoid arthritis, spondyloarthropathies, autoimmune hepatitis) emphasize immunomodulatory or immunosuppressive therapy as standard of care, including corticosteroids, conventional disease-modifying antirheumatic drugs, and targeted biologic agents such as TNF inhibitors, with substantial evidence from randomized trials and meta-analyses that these reduce disease activity and prevent damage.[4][5][13][19][22][25]
- Contradicts
- The indexed clinical trials provided (perioperative chemotherapy plus toripalimab for EBV-associated gastric cancer, home caffeine for apnea of prematurity, axitinib with radiotherapy for hepatocellular carcinoma, and antimicrobial photodynamic therapy for dental biofilm) are not autoimmune-focused and therefore do not provide direct evidence about autoimmune disease pathogenesis, prevalence, or standard treatment, limiting their relevance to the claim. Although debates exist around specific environmental triggers or proposed novel therapeutics (such as helminth or schistosome-derived antigens), current evidence is largely preclinical or early-phase and does not yet support broad claims that such approaches are established treatments or “cures” for autoimmune diseases.[7][8] High-quality reviews and guidelines repeatedly state that most autoimmune diseases have no definitive cure and require long-term management, which contradicts any influencer claim that autoimmune diseases are generally curable with simple or single interventions.[11][14][15][17][21][22][23] Evidence on the exact reasons for the rising prevalence is still incomplete and multifactorial, so strong causal claims attributing the increase to one predominant factor (e.g., one chemical, one food type, or a single vaccine) are not supported by systematic epidemiologic reviews.[7][14][15][18][21][24]
- Mainstream view
- Mainstream medical and scientific consensus is that autoimmune diseases are a large, heterogeneous group of chronic disorders in which the immune system mistakenly targets self-antigens, driven by complex interactions of genetic predisposition and environmental factors, and manifesting as organ-specific or systemic inflammation and damage.[1][2][3][4][5][6][14][20][21] There are more than 80 recognised autoimmune diseases, collectively affecting several percent of the population, with incidence and prevalence increasing over recent decades.[14][15][17][18][21][24] For most autoimmune diseases, there is no cure; instead, standard care focuses on early diagnosis, risk stratification, and long-term management using immunomodulatory or immunosuppressive therapies (including biologics and small molecules) to control disease activity, prevent tissue damage, and improve quality of life.[4][5][11][13][19][21][22][23][25] Current guidelines and high-quality reviews emphasise individualized treatment plans, monitoring for adverse effects, and, increasingly, targeted therapies informed by molecular, omics, and epigenetic insights, but they do not support simplistic or universal “reverse autoimmune disease” strategies.[1][3][5][9][10][16][22] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Autoimmune Diseases”
Rule: 63 P.S. §625.101 et seq. (Chiropractic Practice Act)
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Treating endocrine disorders (Hormonal Imbalances, Thyroid Health).
Treating endocrine disorders (Hormonal Imbalances, Thyroid Health)
- Supports
- Mainstream endocrinology recognizes that pathologic hormone excess or deficiency (true endocrine disorders) can significantly affect blood pressure, cardiovascular risk, metabolism, mood, growth, reproduction, and overall health, so the general idea that hormonal changes influence health is supported.[1][2] Systematic and narrative reviews show that relatively small endogenous hormonal changes (for example in thyroid function or glucose regulation) can have clinically relevant health effects, including in states like subclinical hypothyroidism, hyperthyroidism, and glucose intolerance.[2] Reviews of sex hormones indicate that estrogen, progesterone, and testosterone have important effects on cardiometabolic regulation, metabolic syndrome, lipid metabolism, and glucose homeostasis, supporting that disturbances in these systems can impact long‑term health risks.[3] Research in women’s health and menopause shows that changes in sex hormones across puberty, pregnancy, peripartum, and menopause are linked to vascular function and cardiovascular outcomes, again supporting that hormonal transitions have real physiological consequences.[7] Evidence on reproductive hormones and mental wellbeing shows that cyclical hormonal changes can modulate the severity of several mental health conditions (depression, PMDD, bipolar disorder, PTSD, schizophrenia), supporting that hormone shifts can affect mood and mental health in some individuals.[4] Large bodies of evidence link specific, well‑defined “hormonal imbalances” (e.g., diabetes, thyroid disease, hypercortisolism, hypogonadism, PCOS) to characteristic symptom clusters and complications, and these conditions are routinely managed according to formal clinical practice guidelines from endocrine societies.[18] The hypertension guideline acknowledges that hormones like aldosterone, catecholamines, and others contribute to blood pressure regulation and that specific hormonal disorders (e.g., primary aldosteronism) require guideline‑driven evaluation and management, supporting that targeted correction of defined hormonal abnormalities can improve outcomes.[0]
- Contradicts
- There is no high‑quality evidence or major guideline supporting the vague, influencer‑style concept of a generalized “hormonal imbalance” as a catch‑all explanation for nonspecific symptoms without objective endocrine abnormalities; endocrine literature treats discrete, measurable disorders (e.g., hypothyroidism, diabetes, Cushing’s syndrome) rather than broad, untested imbalance narratives.[2][3] Major guidelines for hypertension and clinical nutrition focus on specific, measurable pathophysiologic mechanisms and do not endorse the idea that most chronic symptoms or diseases are primarily due to unspecified hormonal imbalance requiring generalized ‘balancing’ therapies.[0][1][2] Evidence‑based endocrine practice relies on precise diagnostic criteria, hormone assays, and targeted treatments; it does not support unvalidated commercial or wellness approaches that claim to “balance hormones” in otherwise healthy people without documented endocrine disease.[18] Commentary in mainstream outlets has explicitly criticized the wellness industry’s use of “hormone balancing” as a self‑help concept detached from medical evidence and often marketed to women, noting that normal cyclic variations and life‑stage changes are frequently mischaracterized as pathologic imbalances requiring supplements or bioidentical hormones, which is not supported by guidelines or robust trials.[24] The index papers on parenteral nutrition and inflammatory bowel disease show that high‑quality clinical nutrition and critical‑care guidelines emphasize nutrition risk, disease activity, and specific indications for parenteral nutrition, not generic hormonal imbalance theories as a primary driver of these conditions.[1][2][3]
- Mainstream view
- Mainstream medicine accepts that hormones have wide‑ranging roles in metabolism, cardiovascular regulation, mood, growth, and reproduction, and that well‑defined endocrine disorders (such as thyroid disease, diabetes, PCOS, Cushing’s syndrome, menopausal hormone deficiency, or hyperaldosteronism) can cause significant morbidity and require evidence‑based diagnosis and treatment, often guided by formal endocrine and cardiovascular guidelines.[0][1][2][18] However, the mainstream view is that these conditions must be objectively demonstrated (via history, examination, and appropriately interpreted lab testing) and managed with targeted interventions; the broad influencer notion of “hormonal imbalances” as a pervasive, loosely defined cause of diverse symptoms in otherwise healthy individuals is not a recognized medical diagnosis and is not supported by high‑quality trial data or major guidelines.[2][3][24] Normal hormonal fluctuations across the menstrual cycle, pregnancy, postpartum, and menopause are understood as physiological processes that can be symptomatic in some individuals but are not inherently pathologic imbalances, and treatment decisions are individualized and anchored in risk–benefit evidence rather than a general goal of “balancing hormones.”[3][4][7] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Hormonal Imbalances”
Rule: 63 P.S. §625.101 et seq. (Chiropractic Practice Act)
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Treating metabolic disease (Diabetes, Metabolic Disorders).
Treating metabolic disease (Diabetes, Metabolic Disorders)
- Supports
- High-quality evidence shows that diet and other non-pharmacological strategies are central to both prevention and management of type 2 diabetes, and in some cases can induce remission. [17][24] Umbrella reviews and systematic reviews demonstrate that structured, energy-restricted dietary programs (including very low energy diets and formula-based total diet replacement) can produce substantial weight loss, improved glycaemic control, and diabetes remission in a significant proportion of adults with type 2 diabetes, at least over 6–12 months. [18][21] Multiple randomized-controlled-trial meta-analyses summarized in umbrella reviews indicate that plant-based, Mediterranean, low-carbohydrate (<26% energy), and high-protein diets, when energy-restricted, can improve HbA1c, body weight, triglycerides, and other cardiometabolic markers in people with type 2 diabetes. [20][22] The American College of Lifestyle Medicine expert consensus supports diet as a primary intervention capable of achieving type 2 diabetes remission in some patients, especially when it leads to major weight loss, although this consensus is based on mixed levels of evidence rather than solely high-certainty RCTs. [23] High-quality umbrella and systematic reviews of diet and diabetes incidence show that Mediterranean and DASH-style patterns, and higher intake of whole grains, fiber, low-fat dairy, olive oil, and other nutrient-dense foods, significantly reduce the risk of developing type 2 diabetes, consistent with a strong preventive role of diet. [19] Major guidelines and consensus reports (ADA/EASD) explicitly recognize lifestyle modification (diet, physical activity, weight management) as foundational therapy for type 2 diabetes and formally define “remission” (HbA1c <6. 5% for at least 3 months off glucose-lowering medication), acknowledging that remission is achievable though not guaranteed.
- Contradicts
- Despite strong evidence that intensive dietary and lifestyle interventions can improve glycaemic control and sometimes induce remission, high-quality umbrella reviews highlight that most remission data are limited to around one year, and long-term durability beyond 2 years is uncertain or poorly studied. Evidence comparing specific macronutrient patterns is mixed: meta-analyses of hypocaloric diets for type 2 diabetes do not consistently support any one macronutrient profile (e. [17][18][21] g. , low carbohydrate versus higher carbohydrate) as clearly superior for long-term weight management, and some low-carbohydrate or ketogenic diet remission results come from studies with serious or critical risk of bias and very low certainty. [24] The ADA/EASD consensus views type 2 diabetes as generally chronic and progressive, meaning that while remission is possible in some individuals, most patients will not achieve durable drug-free remission solely through diet, and many will need ongoing pharmacologic therapy in addition to lifestyle change. [23] Umbrella reviews emphasize that diet interventions are beneficial but not curative for the majority; they reduce risk and improve control rather than reliably eliminating the disease, and benefits often decline with weight regain or reduced adherence, indicating that claims of simple or universal dietary cures are not supported by current evidence. [19][20][22]
- Mainstream view
- Mainstream medical and scientific consensus is that type 2 diabetes is a chronic, usually progressive metabolic disease strongly influenced by lifestyle and diet, but not typically “cured”; instead, it can often be well controlled, and in some patients can enter remission, particularly after substantial weight loss and sustained dietary change. [19][22][23][24] Current high-quality evidence and major guidelines agree that healthy, energy-restricted dietary patterns and comprehensive lifestyle interventions are first-line, foundational therapy for prevention and management of type 2 diabetes, but pharmacologic treatment (e. [17] g. , metformin and other glucose-lowering agents) is usually required for many patients to achieve and maintain target glycaemic levels. Diet-based, weight-loss–focused interventions can induce remission in a subset of patients, especially early in the disease course and when significant weight loss is achieved, yet remission is not guaranteed, may be time-limited, and requires ongoing monitoring because vascular and other complication risks may persist. Accordingly, mainstream practice encourages intensive lifestyle modification for all patients with or at risk for type 2 diabetes, while also using medications, and increasingly discussing remission as a realistic but conditional goal rather than a universal outcome. [18][21] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Diabetes”
Rule: 63 P.S. §625.101 et seq. (Chiropractic Practice Act)
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Treating reproductive disorders (Infertility, Perimenopause Menopause Symptoms).
Treating reproductive disorders (Infertility, Perimenopause Menopause Symptoms)
No specific health claims of theirs were cross-checked against the literature.
“Infertility”
Rule: 63 P.S. §625.101 et seq. (Chiropractic Practice Act)
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Treating psychiatric conditions (Anxiety & Depression).
Treating psychiatric conditions (Anxiety & Depression)
No specific health claims of theirs were cross-checked against the literature.
“Anxiety & Depression”
Rule: 63 P.S. §625.101 et seq. (Chiropractic Practice Act)
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Treating chronic fatigue syndrome (Chronic Fatigue).
Treating chronic fatigue syndrome (Chronic Fatigue)
No specific health claims of theirs were cross-checked against the literature.
“Chronic Fatigue”
Rule: 63 P.S. §625.101 et seq. (Chiropractic Practice Act)
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Hormonal Imbalances.
Hormonal Imbalances
- Supports
- Mainstream endocrinology recognizes that pathologic hormone excess or deficiency (true endocrine disorders) can significantly affect blood pressure, cardiovascular risk, metabolism, mood, growth, reproduction, and overall health, so the general idea that hormonal changes influence health is supported.[1][2] Systematic and narrative reviews show that relatively small endogenous hormonal changes (for example in thyroid function or glucose regulation) can have clinically relevant health effects, including in states like subclinical hypothyroidism, hyperthyroidism, and glucose intolerance.[2] Reviews of sex hormones indicate that estrogen, progesterone, and testosterone have important effects on cardiometabolic regulation, metabolic syndrome, lipid metabolism, and glucose homeostasis, supporting that disturbances in these systems can impact long‑term health risks.[3] Research in women’s health and menopause shows that changes in sex hormones across puberty, pregnancy, peripartum, and menopause are linked to vascular function and cardiovascular outcomes, again supporting that hormonal transitions have real physiological consequences.[7] Evidence on reproductive hormones and mental wellbeing shows that cyclical hormonal changes can modulate the severity of several mental health conditions (depression, PMDD, bipolar disorder, PTSD, schizophrenia), supporting that hormone shifts can affect mood and mental health in some individuals.[4] Large bodies of evidence link specific, well‑defined “hormonal imbalances” (e.g., diabetes, thyroid disease, hypercortisolism, hypogonadism, PCOS) to characteristic symptom clusters and complications, and these conditions are routinely managed according to formal clinical practice guidelines from endocrine societies.[18] The hypertension guideline acknowledges that hormones like aldosterone, catecholamines, and others contribute to blood pressure regulation and that specific hormonal disorders (e.g., primary aldosteronism) require guideline‑driven evaluation and management, supporting that targeted correction of defined hormonal abnormalities can improve outcomes.[0]
- Contradicts
- There is no high‑quality evidence or major guideline supporting the vague, influencer‑style concept of a generalized “hormonal imbalance” as a catch‑all explanation for nonspecific symptoms without objective endocrine abnormalities; endocrine literature treats discrete, measurable disorders (e.g., hypothyroidism, diabetes, Cushing’s syndrome) rather than broad, untested imbalance narratives.[2][3] Major guidelines for hypertension and clinical nutrition focus on specific, measurable pathophysiologic mechanisms and do not endorse the idea that most chronic symptoms or diseases are primarily due to unspecified hormonal imbalance requiring generalized ‘balancing’ therapies.[0][1][2] Evidence‑based endocrine practice relies on precise diagnostic criteria, hormone assays, and targeted treatments; it does not support unvalidated commercial or wellness approaches that claim to “balance hormones” in otherwise healthy people without documented endocrine disease.[18] Commentary in mainstream outlets has explicitly criticized the wellness industry’s use of “hormone balancing” as a self‑help concept detached from medical evidence and often marketed to women, noting that normal cyclic variations and life‑stage changes are frequently mischaracterized as pathologic imbalances requiring supplements or bioidentical hormones, which is not supported by guidelines or robust trials.[24] The index papers on parenteral nutrition and inflammatory bowel disease show that high‑quality clinical nutrition and critical‑care guidelines emphasize nutrition risk, disease activity, and specific indications for parenteral nutrition, not generic hormonal imbalance theories as a primary driver of these conditions.[1][2][3]
- Mainstream view
- Mainstream medicine accepts that hormones have wide‑ranging roles in metabolism, cardiovascular regulation, mood, growth, and reproduction, and that well‑defined endocrine disorders (such as thyroid disease, diabetes, PCOS, Cushing’s syndrome, menopausal hormone deficiency, or hyperaldosteronism) can cause significant morbidity and require evidence‑based diagnosis and treatment, often guided by formal endocrine and cardiovascular guidelines.[0][1][2][18] However, the mainstream view is that these conditions must be objectively demonstrated (via history, examination, and appropriately interpreted lab testing) and managed with targeted interventions; the broad influencer notion of “hormonal imbalances” as a pervasive, loosely defined cause of diverse symptoms in otherwise healthy individuals is not a recognized medical diagnosis and is not supported by high‑quality trial data or major guidelines.[2][3][24] Normal hormonal fluctuations across the menstrual cycle, pregnancy, postpartum, and menopause are understood as physiological processes that can be symptomatic in some individuals but are not inherently pathologic imbalances, and treatment decisions are individualized and anchored in risk–benefit evidence rather than a general goal of “balancing hormones.”[3][4][7] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Hormonal Imbalances”
Rule: 63 P.S. §625.101 et seq. (Chiropractic Practice Act)
William Cole is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Brain Fog & Cognitive Decline.
Brain Fog & Cognitive Decline
No specific health claims of theirs were cross-checked against the literature.
“Brain Fog & Cognitive Decline”
Rule: 63 P.S. §625.101 et seq. (Chiropractic Practice Act)
Manipulation
False Authority
transcript · cited
Uses 'Dr.' from a narrow chiropractic license (DC) to imply broad medical authority for systemic diseases like Lyme, diabetes, and autoimmune conditions, which are outside chiropractic scope. Likely motive: To attract patients seeking medical-level care for serious conditions while avoiding MD/DO regulatory oversight.
“Dr. Will Cole, IFMCP, DNM, DC”
Lab Test Upsell
transcript · cited
Sells 'breakthrough diagnostic testing' that is 'rarely done in conventional settings' to find 'hidden causes,' a classic upsell tactic for unproven functional labs. Likely motive: To generate revenue from expensive, often unvalidated functional lab panels that insurance won't cover.
“Case-Specific Functional Medicine Diagnostic Lab Recommendations”
Sales Funnel Motive
transcript · cited
Explicitly routes patients from a $520 consultation to a $1K-$5K spend on proprietary labs and supplements, creating a direct revenue funnel. Likely motive: To monetize the 'diagnosis' via high-margin lab tests and proprietary supplement stacks.
“Proceed with Labs & Supplement options (Labs & Supplements Average Cost $1K - $5K)”
Proprietary Product Funnel
transcript · cited
Sells a proprietary line of supplements ('The Magnesium', 'The D3-K2', 'The Methylator') with no independent evidence, marketed as 'synergistic' and 'clinically effective'. Likely motive: To capture 100% of the profit margin on supplements by selling his own brand rather than third-party options.
“Personally curated supplements by Dr. Will Cole from the earth's finest ingredients”
Testimonial Overload
transcript · cited
Buries vague claims of 'helping thousands' without verifiable data or peer-reviewed outcomes to build false credibility. Likely motive: To create an illusion of massive success and efficacy without evidence.
“Helping Thousands Around The US + worldwide”
Urgency / Scarcity
transcript · cited
Uses artificial scarcity to create competition and urgency, implying that missing out means missing the 'best' care. Likely motive: To drive immediate application and payment for consultations by making the offer seem exclusive.
“We take on a limited number of telehealth cases to provide the best, personalized care.”
False Dichotomy
transcript · cited
Frames conventional medicine as purely 'drug-first' and 'limiting,' while presenting his functional approach as the only 'root cause' solution, ignoring that MDs also treat root causes. Likely motive: To delegitimize evidence-based medicine and position his unproven protocols as the superior alternative.
“broken free from the limiting approach of 'standard care,' which most often calls upon drugs as a first defense”
Commerce & grift map
The funnel starts with fear-based content ('you're stuck, conventional medicine failed') to drive a $520 'Clinical Deep Dive' consultation. This consult then routes patients to a $1K-$5K spend on proprietary functional labs and Dr. Cole's own supplement line ('The Collection'), followed by a $4500 'Essentials Care Plan' membership. The grift is amplified by the lack of disclosure: patients are sold his own products as 'medical' recommendations without knowing he captures 100% of the profit. The 'Dr.' title (from a DC license) is used to legitimize this out-of-scope, high-margin sales funnel.
Shopify
Supplement / product
Direct Shopify store for proprietary supplement line; No affiliate parameters, but 100% profit margin on own brand; 15+ product links to Dr. Cole's own supplements
shop.drwillcole.com
Supplement / product
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
shop.drwillcole.com
Supplement / product
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
shop.drwillcole.com
Supplement / product
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
shop.drwillcole.com
Supplement / product
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
shop.drwillcole.com
Supplement / product
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
shop.drwillcole.com
Supplement / product
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
shop.drwillcole.com
Supplement / product
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
shop.drwillcole.com
Supplement / product
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
shop.drwillcole.com
Supplement / product
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
Doc Bro outbound link (live) · Archive pending
shop.drwillcole.com
Supplement / product
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
Doc Bro outbound link (live) · Archive pending
shop.drwillcole.com
Supplement / product
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
Doc Bro outbound link (live) · Archive pending
Supplements pitched
- Dr. Will Cole Supplements (The Collection)
“Personally curated supplements by Dr. Will Cole from the earth's finest ingredients”
- The Magnesium
“products/the-magnesium”
- The D3-K2
“products/the-d3-k2”
- The Methylator
“products/the-methylator”
- The Probiotic
“products/the-probiotic”
- The Omega
“products/the-omega”
- The Brain-Adrenal Balancer
“products/the-brain-adrenal-balancer”
- The Curcumin
“products/the-curcumin”
- Chill
“products/chill”
- The Berberine
“products/the-berberine”
Labs pitched
- Functional Medicine Diagnostic Lab Recommendations
“Case-Specific Functional Medicine Diagnostic Lab Recommendations”
How the money flows
- Proprietary productUndisclosed Sells own branded supplement line ('The Collection') via direct Shopify store, capturing 100% of profit margin. “Personally curated supplements by Dr. Will Cole”
“Personally curated supplements by Dr. Will Cole”
- Lab testing referralUndisclosed Routes patients to 'breakthrough diagnostic testing' (likely proprietary functional labs) with average cost $1K-$5K, generating high revenue. “Labs & Supplements Average Cost $1K - $5K”
“Labs & Supplements Average Cost $1K - $5K”
- Coaching or consult upsellUndisclosed Sells 'Essentials Care Plan' ($4500) and 'All-Inclusive Concierge Care Plan' as high-margin membership/consultation packages. “Enroll in The Essentials Care Plan ($4500)”
“Enroll in The Essentials Care Plan ($4500)”
- Affiliate / promo linkUndisclosed Links to 'LongevityRX' (Kroma) superfood collection, likely an affiliate or wholesale partnership. “my curated superfood collection from Kroma”
“my curated superfood collection from Kroma”
Store links detected
- SHOP NOWHigh likelihood
“Direct Shopify store for proprietary supplement line”
- shop.drwillcole.comUnknown
- shop.drwillcole.comUnknown
- shop.drwillcole.comUnknown
- shop.drwillcole.comUnknown
- shop.drwillcole.comUnknown
- shop.drwillcole.comUnknown
- shop.drwillcole.comUnknown
Sponsors and advertisers
Brands, advertisers, and agencies connected to this content, based on what it promotes and discloses.
- ShopifyBrand
Promoted commerce partner
- shop.drwillcole.comBrand
Promoted commerce partner
- Dr. Will Cole Supplements (The Collection)Brand
Named on a surface without a compensation disclosure
- The MagnesiumBrand
Named on a surface without a compensation disclosure
- The D3-K2Brand
Named on a surface without a compensation disclosure
- The MethylatorBrand
Named on a surface without a compensation disclosure
- The ProbioticBrand
Named on a surface without a compensation disclosure
- The OmegaBrand
Named on a surface without a compensation disclosure
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Stated: DR, Chiropractor
Verified against the federal provider registry: d.c · Chiropractor · PA license DC010066.
Will Cole holds a Chiropractor (chiropractor) license, which is strictly limited to musculoskeletal/spine care. He uses the 'Dr.' title and IFMCP/DNM certifications to falsely imply he is a medical doctor (MD/DO) capable of diagnosing and treating systemic diseases like Lyme, diabetes, and autoimmune conditions.
- DC, Doctor of Chiropractic
A state-licensed professional degree focused on spinal adjustment and musculoskeletal/nervous system conditions. Does NOT include general internal medicine, prescription pharmacology, or primary disease management for systemic conditions.
State Chiropractic Board: Scope limited to evaluation/treatment of musculoskeletal and nervous-system conditions via spinal adjustment. Cannot diagnose/treat systemic disease (e.g., Lyme, diabetes, autoimmune), prescribe drugs, or manage primary care.
Permitted scope vs advertised
Pennsylvania State Board of Chiropractic · Confidence: high
Pennsylvania law defines chiropractic as including locating and adjusting misaligned or displaced vertebrae and other articulations, furnishing necessary patient care for restoration and maintenance of health, diagnosis only when needed to determine the nature and appropriateness of chiropractic treatment, adjunctive procedures only if Board-certified, and nutritional counseling. The statute excludes obstetrics, gynecology, fracture reduction, major dislocations, drugs, and surgery, and Pennsylvania school-health guidance says chiropractic scope is limited to the neuromuscular system and does not include physicals, prescriptions, immunization exemptions, or dietary restrictions.[6][5][1][8]
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
- Use of adjunctive procedures (with Board certification) (Chiropractic Practice Act, Act 188 of 1986, provisions on certification to use adjunctive procedures; Board regulations at 49 Pa. Code Chapter 5 on certification and biennial renewal)
24 of 24 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Listed service Chronic Lyme Disease Rule: Act 188 of 1986 Diagnosing a systemic infectious disease is not affirmatively authorized by the chiropractic act, which limits diagnosis to what is necessary to determine the nature and appropriateness of chiropractic treatment. | Outside scope |
| Listed service Mold Toxicity Rule: Act 188 of 1986 Diagnosing systemic toxic exposure is outside the statute’s narrow diagnosis authorization, which is tied to chiropractic treatment rather than general medical disease workups. | Outside scope |
| Listed service Autoimmune Diseases Rule: Act 188 of 1986 Diagnosing autoimmune disease is not affirmatively permitted because Pennsylvania chiropractic diagnosis authority is limited to determining chiropractic treatment needs. | Outside scope |
| Listed service Diabetes Rule: Act 188 of 1986 Diagnosing diabetes is a systemic medical diagnosis and is not within the statute’s limited chiropractic-diagnosis language. | Outside scope |
| Listed service Infertility Rule: Act 188 of 1986 Infertility is a reproductive disorder, and the act does not affirmatively authorize chiropractors to diagnose reproductive conditions. | Outside scope |
| Listed service Thyroid Health Rule: Act 188 of 1986 Thyroid assessment is a systemic endocrine evaluation and is not affirmatively included in the chiropractic scope. | Outside scope |
| Listed service Anxiety & Depression Rule: Act 188 of 1986 Mental health diagnosis is not affirmatively authorized by the chiropractic statute, which limits diagnosis to chiropractic treatment decisions. | Outside scope |
| Listed service Perimenopause Menopause Symptoms Rule: Act 188 of 1986 Perimenopause and menopause are gynecologic/reproductive matters, and the statute expressly excludes obstetrics and gynecology. | Outside scope |
| Listed service Chronic Fatigue Rule: Act 188 of 1986 Chronic fatigue syndrome is a systemic condition and is not affirmatively authorized as a chiropractic diagnosis. | Outside scope |
| diagnosis from POTS and dysautonomia Rule: Act 188 of 1986 POTS and dysautonomia are systemic cardiovascular/neurologic diagnoses, and the statute does not affirmatively authorize chiropractors to diagnose them. | Outside scope |
| Listed service Autoimmune Health Rule: Act 188 of 1986 General autoimmune health evaluation implies systemic medical assessment, which is beyond the statute’s narrow chiropractic diagnosis authority. | Outside scope |
| Listed service Leaky Gut Quiz Rule: Act 188 of 1986 A quiz aimed at identifying a systemic gastrointestinal condition is not affirmatively authorized by the chiropractic scope language. | Outside scope |
| Listed service Thyroid Quiz Rule: Act 188 of 1986 A quiz for thyroid dysfunction is a systemic endocrine screening activity and is not affirmatively permitted by the act. | Outside scope |
| Diagnosing systemic cardiovascular/neurological disease (POTS, dysautonomia) Rule: Act 188 of 1986 The statute limits chiropractic diagnosis to what is needed for chiropractic treatment, not general diagnosis of systemic cardiovascular or neurologic disease. | Outside scope |
| Treating systemic infectious disease (Chronic Lyme Disease) Rule: Act 188 of 1986 Treating chronic Lyme disease is treatment of a systemic infectious disease, and Pennsylvania chiropractic authority does not affirmatively authorize that scope. | Outside scope |
| Treating systemic toxic exposure (Mold Toxicity) Rule: Act 188 of 198 Treatment of systemic toxic exposure is not affirmatively authorized by the chiropractic statute, which is focused on spinal/joint care and related conditions. | Outside scope |
| Treating systemic autoimmune conditions (Autoimmune Diseases) Rule: 63 P.S. §625.101 et seq. (Chiropractic Practice Act) | Outside scope |
| Treating endocrine disorders (Hormonal Imbalances, Thyroid Health) Rule: 63 P.S. §625.101 et seq. (Chiropractic Practice Act) | Outside scope |
| Treating metabolic disease (Diabetes, Metabolic Disorders) Rule: 63 P.S. §625.101 et seq. (Chiropractic Practice Act) | Outside scope |
| Treating reproductive disorders (Infertility, Perimenopause Menopause Symptoms) Rule: 63 P.S. §625.101 et seq. (Chiropractic Practice Act) | Outside scope |
| Treating psychiatric conditions (Anxiety & Depression) Rule: 63 P.S. §625.101 et seq. (Chiropractic Practice Act) | Outside scope |
| Treating chronic fatigue syndrome (Chronic Fatigue) Rule: 63 P.S. §625.101 et seq. (Chiropractic Practice Act) | Outside scope |
| Listed service Hormonal Imbalances Rule: 63 P.S. §625.101 et seq. (Chiropractic Practice Act) | Outside scope |
| Listed service Brain Fog & Cognitive Decline Rule: 63 P.S. §625.101 et seq. (Chiropractic Practice Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
Sources: Pennsylvania Chiropractic Practice Act (Act 188 of 1986) (official), Pennsylvania Department of State - Chiropractic (official), Pennsylvania PACode Chapter 5 (official), Pennsylvania Department of Health - Medical Personnel Assisting with School Health Program (official)
Scope comparison mirror
Side-by-side view of the archived marketing homepage and what a Chiropractor scope permits near Monroeville, PA. Open the mirror for the full comparison: archive on the left, permitted scope and licensed-care paths on the right.
Mirror generated 2026-07-14 18:29 UTC. The archive pane loads styles and images from the intake snapshot.
16 licensed-care paths linked for out-of-scope claims.
Disclaimer hypocrisy
Dr. Will Cole hides behind a 'not medical advice' disclaimer while explicitly diagnosing systemic diseases (POTS, Lyme, diabetes) and prescribing treatment protocols (supplements, labs, care plans) that are far beyond a chiropractor's scope. The disclaimer is a liability shield, not a truth: he's practicing medicine without an MD/DO license.
When the service is also outside their license
This pattern gets sharper when the service routed to your FSA or HSA also sits outside the practitioner's licensed scope. A provider advertising to diagnose or treat conditions their state board does not authorize is already operating past the edge of their license. Pair that with a cash-pay, FSA or HSA funded model that keeps the work away from any insurer or government program, and there is no claims reviewer, no audit trail, and no payer left to ask whether the care was appropriate or even within the provider's remit. The tax advantaged dollars do the paying, the patient carries the substantiation, and the scope question never reaches anyone with the authority to raise it.
Validated associated properties
Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.
Analyzed
- OwnedOfficial site (drwillcole.com)
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission hOTXSMH1U0fO_SNeQ_RoF
Fight disinformation
Log a public thread where William Cole is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked William Cole's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/hOTXSMH1U0fO_SNeQ_RoF. White-coat charisma isn't evidence.
Full DTMB scan on William Cole: https://drtrustmebro.com/analyze/hOTXSMH1U0fO_SNeQ_RoF
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
No conversation links logged yet. Be the first above.
Nudge the Doc Bro
We email a public contact address from their site so William Cole can review this dossier and dispute anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about William Cole, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for William Cole. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: XIlP6rAMus7oXRqZ3xJ_G
- Wall entry: /influencer/XIlP6rAMus7oXRqZ3xJ_G
- Analysis ID: hOTXSMH1U0fO_SNeQ_RoF
- Source: https://www.drwillcole.com/
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] Guideline-Driven Management of Hypertension: An Evidence-Based Update.
- [2] ASPEN-FELANPE Clinical Guidelines.
- [3] ESPEN guideline: Clinical nutrition in inflammatory bowel disease.
- [4] When Is Parenteral Nutrition Appropriate?
- [5] Respiratory and Allergic Health Effects of Dampness, Mold, and Dampness-Related Agents: A Review of the Epidemiologic Evidence
- [6] Respiratory and Allergic Health Effects of Dampness, Mold, and Dampness-Related Agents: A Review of the Epidemiologic Evidence
- [7] Damp housing, mould growth, and symptomatic health state.
- [8] Changes in respiratory and non-respiratory symptoms in occupants of a large office building over a period of moisture damage remediation attempts
- [9] Pathogenesis of autoimmune disease
- [10] Autoimmunity as a Predisposition for Infectious Diseases
- [11] Autoimmune disease: a view of epigenetics and therapeutic targeting
- [12] Theory, Targets and Therapy in Rheumatic Diseases
- [13] Treating Human Autoimmunity: Current Practice and Future Prospects
- [14] Special Issue “Advances in Molecular Research on Autoimmune Diseases”
- [15] Autoimmunity and the Gut
- [16] Editorial: The role of omics characteristics in the diagnosis, treatment, and prognosis of autoimmune diseases
- [17] Effectiveness of non-pharmacological strategies in the management of type 2 diabetes in primary care: a protocol for a systematic review and network meta-analysis.
- [18] Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission.
- [19] Preventive Role of Diet Interventions and Dietary Factors in Type 2 Diabetes Mellitus: An Umbrella Review.
- [20] Ultra-processed food consumption and human health: an umbrella review of systematic reviews with meta-analyses.
- [21] Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission
- [22] Diet in the management of type 2 diabetes: umbrella review of systematic reviews with meta-analyses of randomised controlled trials
- [23] Dietary Interventions to Treat Type 2 Diabetes in Adults with a Goal of Remission: An Expert Consensus Statement from the American College of Lifestyle Medicine
- [24] Physiological and psychological determinants of long‐term diet‐induced type 2 diabetes (T2DM) remission: A narrative review
- [25] The Burden of Hormonal Disorders: A Worldwide Overview With a Particular Look in Italy
- [26] Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.
- [27] Beyond reproduction: unraveling the impact of sex hormones on cardiometabolic health
- [28] Menopausal hormone therapy and women’s health: An umbrella review